Skip to content

Outcomes of bilateral cataract surgery with a new extended range of vision intraocular lens

Visual Outcomes Comparing Emmetropia versus Mini Monovision following bilateral implantation of a non-diffractive extended vision IOL : Randomized Trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/07/035242
Enrollment
140
Registered
2021-07-29
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H251- Age-related nuclear cataract

Interventions

Intervention1: Cataract surgery with Vivity Intraocular Lens: Cataract surgery with Vivity Intraocular Lens Intervention2: Target refraction bilateral emmetropia: Study visual acuity 6 months followin

Sponsors

Alcon Laboratiores USA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age related cataract with nuclear sclerosis ranging grade I to IV on the LOCS III grading system or clear crystalline lens undergoing refractive lens exchange. Both eyes of each patient will be included.

Exclusion criteria

Exclusion criteria: Ocular comorbidities

Design outcomes

Primary

MeasureTime frame
Binocular Unaided Near Visual acuity at 40cm Timepoint: 6 months postoperatively

Secondary

MeasureTime frame
Binocular unaided intermediate visual acuity at 66cmTimepoint: 6 months

Countries

India

Contacts

Public ContactDr Abhay R Vasavada

Raghudeep Eye Hospital

icirc@abhayvasavada.com917927490909

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026